Clinical trial
Endothelial Cell Dysfunction in Pulmonary Hypertension
NCT00098072 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00098072 |
|---|---|
| Title | Endothelial Cell Dysfunction in Pulmonary Hypertension |
| Official title | Endothelial Cell Dysfunction in Pulmonary Arterial Hypertension: Biomarkers, Mechanisms of Disease and Novel Therapeutic Targets |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Secondary Pulmonary Arterial Hypertension |
| Intervention type | Procedure |
| Interventions | Heart Catheterization |
| Enrollment | 27 |
| Start date | May 17, 2000 |
| Primary completion | Jul 8, 2009 |
| Completion | Jul 8, 2009 |
| First posted | Dec 3, 2004 |
| Last update posted | Jan 16, 2026 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: